Endocrine_responses_to_long-term_administration_of_the_antiprogesterone_RU486_in_patients_with_pelvic_endometriosis._OBJECTIVE:_To_examine_endocrine_and_clinical_responses_to_long-term_administration_of_RU486_in_patients_with_endometriosis._DESIGN:_Prospective_open_trial._SETTING:_Faculty_practice_of_the_authors._PATIENTS,_PARTICIPANTS:_Six_normally_cycling_women_with_endometriosis_were_recruited._INTERVENTIONS:_Subjects_received_RU486_100_mg/d_for_3_months._MAIN_OUTCOME_MEASURE(S):_Hormonal_changes_during_RU486_were_compared_with_control_data_obtained_in_the_preceding_cycle_during_the_early_follicular_phase._Clinical_responses_were_determined_by_patient_assessment_and_second-look_laparoscopy._RESULTS:_All_women_became_amenorrheic,_and_daily_urinary_levels_of_ovarian_steroid_metabolites_remained_acyclic._Mean_luteinizing_hormone_(LH)_(P_less_than_0.02)_and_LH_pulse_amplitude_(P_less_than_0.05)_were_increased_without_changes_in_LH_pulse_frequency._An_antiglucocorticoid_effect_was_demonstrated_by_an_increase_in_serum_cortisol_(P_less_than_0.01)_and_adrenocorticotropic_hormone_(P_less_than_0.05)_levels._Treatment_resulted_in_an_improvement_in_pelvic_pain_in_all_subjects_without_significant_change_in_the_extent_of_disease_as_evaluated_by_follow-up_laparoscopy._CONCLUSIONS:_Daily_administration_of_RU486_results_in_acyclic_ovarian_function_and_improvement_in_the_subjective_painful_symptoms_of_endometriosis.